Dr. Lisa Fitzpatrick believes plainspoken information from trusted messengers can help shrink health disparities, and some insurers are buying in.
Podcast
Posted inCost of Care
The End of Humira’s $200 Billion Drug Monopoly
What will happen when the best selling drug ever finally faces direct competition?
Posted inPublic Health
Three Health Policy Stories to Watch in 2023
In 2023, states will pursue new abortion laws, restart Medicaid eligibility checks and Medicare will begin to flex its new power to negotiate drug prices.
Posted inPublic Health
Best Health Care Podcasts of 2022
Our annual look at some of the best health care podcast episodes of the year with help from a few of our podcast host friends.
Posted inMental Health
Local Officials Grapple With How to Spend Billions in Opioid Settlement Dollars
More than $50 billion in opioid settlement dollars from drugmakers, distributors and pharmacies are starting to flow to state and local governments.
Posted inHealth Equity
The Hurdles Facing Black Families Navigating Serious Illness
What stops seriously ill Black patients and their families from getting the care they want in life and in death?
Posted inCost of Care
‘A Shocking Amount of Misery’: Medical Debt in America
We talk about the impact medical debt can have on people’s lives and what research tells us about possible solutions.
Posted inInsurance
Medicare’s Prescription Drug Plan Makeover
An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.
Posted inWorkforce
Turning Long-Term Care Into a Long-Term Career
There’s a severe shortage of people to care for older Americans. Could providing workers with new career pathways be part of the solution?
Posted inWorkforce
The ‘Wild West’ of Health Workforce Policy
The pandemic has reignited long-standing turf wars among health professions, and state lawmakers are caught in the middle.